← back to search

Carlo Ferrari

University of Padua · IT
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Medicine, HBsAg, Biology, Hepatitis B virus, Genome-wide association study, and Chronic hepatitis.
h-index
citations
1,757
works
10
NIH funding
primary concept
email

Recent publications

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Journal of Hepatology 2021cited by 180position: middledoi
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection
Nature Communications 2020cited by 66position: lastdoi
A global scientific strategy to cure hepatitis B
˜The œLancet. Gastroenterology & hepatology 2019cited by 494position: middledoi
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
Journal of Hepatology 2019cited by 357position: middledoi
RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection
Hepatology 2019cited by 132position: middledoi
Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort
Hepatology 2017cited by 29position: middledoi
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel
Digestive and Liver Disease 2017cited by 21position: middledoi
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
Nature Communications 2015cited by 309position: middledoi
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection
Journal of Clinical Investigation 2013cited by 96position: middledoi
Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells
Gastroenterology 2012cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2012–2020)Antonio Bertoletti · Duke-NUS Medical School2 papers (2012–2013) · 1 papers (2020–2020)Ju H. Kim · Houston Methodist1 papers (2019–2019) · 1 papers (2013–2013) · 1 papers (2020–2020) · 1 papers (2020–2020)Chiara Romualdi · University of Padua1 papers (2020–2020) · 1 papers (2020–2020)Andrea Vecchi · Trenitalia (Italy)1 papers (2020–2020)James Hamilton · Palo Alto University1 papers (2019–2019)Stephen Locarnini · Monash University1 papers (2019–2019)Tsunamasa Watanabe · Second Affiliated Hospital of Xi'an Jiaotong University1 papers (2012–2012) · 1 papers (2020–2020)Elena Sandalova · Utrecht University1 papers (2012–2012) · 1 papers (2020–2020)Ching‐Lung Lai · Novartis (China)1 papers (2019–2019)Adeline Chia · National University of Singapore1 papers (2013–2013) · 1 papers (2020–2020)Amanda Shin · Shanghai Jiao Tong University1 papers (2013–2013)